| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 |
| filingDate |
1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66c89340b975b1415e67346221f181aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4383ed53bc15a770159ae0aec55c34b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6dd479d846f22efaa97d9e4322064beb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b6f0e22a5ee14b8b2bd9c2e46ba4144 |
| publicationDate |
2001-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CZ-20004051-A3 |
| titleOfInvention |
An ester as a sPLA2 inhibitor |
| abstract |
N-Morpholinoethyl [(3- (2-amino-1,2-dioxoethyl) -2-nmethyl 1- (phenylmethyl) -1H-indol-4-yl) oxy] acetic acid isndescribed together with its use as highly bioavailablenindole inhibitor aPLA2. |
| priorityDate |
1999-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |